ClinicalTrials.gg
CompletedNCT03445598Updated Jul 2, 2019

Automated and Personalized Cognitive Behavioral Therapy

An interventional study of Interactive and personalized CCBT and Feature-limited CCBT in Depressive Symptoms, sponsored by Indian Institute of Technology Kanpur. Completed at 1 site in India. Open to participants aged 16 Years to 35 Years. Per ClinicalTrials.gov, last updated 2019-07-02.

Sponsored by Indian Institute of Technology Kanpur · Not applicable, Interventional, and Supportive care

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
600
Allocation
Randomized
Ages
16 Years to 35 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 59 studies in Depression with a site in India — 6 open to participants now, 7 under way, 1 of them phase 3. Depression · India.

Enrollment
16th of 55
600 · median 319
Started
2018
with 2 others
No phase
35 of 59
5 open now
Registered
29th of 59
by date
Lead sponsor
2 of 59
Indian Institute of Technology Kanpur

Among the 59 studies in Depression with a site in India, this one is the 16th largest by enrollment of the 55 interventional ones that give a count, is one of 3 that started in 2018, is one of 35 with no phase, and was the 29th registered.

Depression

8,582 studies on the registry are indexed under Depression; 1,723 are open to participants now.

Browse Depression studies →

Open to participants now

6 of the 59 studies in Depression with a site in India are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in India have not opened yet or have stopped. Only those recruiting at a site in India →

Who these studies take

Of the 1,089 Depression studies recruiting now, 470 (43%) set no upper age limit and 519 (48%) stop at 75 or younger; 203 take children under 18; 311 take healthy volunteers.

This study: 16 Years to 35 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 59 studies in Depression with a site in India, or all of them as a file.
02

Study summary

This study is designed to evaluate a novel online tool to deliver computerized Cognitive Behavioral Therapy (CBT). Participants will be randomized into three groups: experimental, active control, and waitlist. Participants in the experimental group will have access to the full-featured online tool designed to deliver CBT in an interactive and personalized manner. The participants in the active control group will have access to a limited version of the online tool designed to deliver basic CBT in plain text format. The waitlisted participants will be put on a waitlist for 6 weeks. We hypothesize that the experimental group participants will show a significantly higher reduction in depression symptom severity and will show increased engagement and adherence to the online tool.

Read the detailed description

Depression is a major psychiatric disorder globally, including in India. One of the most effective approaches to treat depression is Cognitive Behavioral Therapy (CBT), but its reach is limited by the dearth of trained psychiatrists, especially in remote areas, and the high costs and stigma associated with visits to a psychiatric clinic. Delivering CBT through a computer, with limited or no intervention from a psychiatrist, could address these limitations. Computerized Cognitive Behavioral Therapy (CCBT) is thus emerging as a more accessible and economical alternative to CBT. Despite some evidence of its efficacy, CCBT use is limited because the existing software programs used to deliver the therapy provide a much lower level of personalization and engagement than in-person therapy. The objective of this study is to assess if the new algorithm makes CCBT more efficacious, acceptable and engaging to users. Depression severity as measured by the Patient Health Questionnaire-9 (PHQ-9) is expected to reduce over the duration of the study, more significantly in the treatment group compared to the control group. Participants will be recruited online through a website that will check compatibility with inclusion/exclusion criteria and get the informed consent.

03

Conditions studied

  • Depressive Symptoms

Keywords

  • depression
  • anxiety
  • CBT
  • psychotherapy
  • e-health
  • CCBT
04

Who can participate

Ages eligible
16 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Fluent in English
  • PHQ-9 Score from 5 to 19
  • Access to internet-connected computer or tablet device
  • Country: India

Exclusion criteria

Exclusion Criteria:

  • Suicide ideation (score greater than 0 on the 9th question of PHQ-9)
  • Unemployed
  • Current or previous diagnosis of bipolar disorder/manic-depressive disorder or psychosis
  • Prospective participants who say they only want to check out the program and do not plan to complete it are excluded.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
600 participants (actual)

Study arms

  • Experimental
    Interactive CCBT group

    This group receives Interactive and Personalized CCBT

    Behavioral: Interactive and personalized CCBT

  • Active comparator
    Limited CCBT control group

    This group receives Feature-limited CCBT

    Behavioral: Feature-limited CCBT

  • Other
    Waitlist control group

    This group receives waitlist control

    Other: Waitlist control

Interventions

  • BehavioralInteractive and personalized CCBT

    Participants will go through an automated program. Participants will learn and practice the techniques of CBT through multimedia elements along with personalized content and interactive features in the program

  • BehavioralFeature-limited CCBT

    Participants will be going through an automated program. Participants will learn and practice the techniques of CBT in a plain-text format with reduced features.

  • OtherWaitlist control

    Participants will be put on a waitlist for a period of 6 weeks.

06

What researchers measure

Primary outcomes

  1. Change in Patient Health Questionnaire-9 score

    Standard questionnaire for depressive symptoms. Total score is used; lower score indicates better outcome.

    Time frame: change from baseline to program completion or last usage (upto 90 days).

Secondary outcomes

  1. Change in Generalized Anxiety Disorder 7 score

    Standard questionnaire for generalized anxiety symptoms. Total score is used; lower score indicates better outcome.

    Time frame: baseline, post-completion or last usage (upto 90 days), 90 day follow-up after completion

  2. Time spent with the program

    Automated measure of time spent on the program for experimental and active comparator group

    Time frame: from beginning till last usage (upto 180 days)

  3. Follow-up Patient Health Questionnaire-9 score

    Standard questionnaire for depressive symptoms. Total score is used; lower score indicates better outcome.

    Time frame: 90 days after program completion

Other outcomes

  1. Change in Patient Health Questionnaire-9 score (Intermediate reports)

    Standard questionnaire for depressive symptoms. Total score is used; lower score indicates better outcome.

    Time frame: after modules 1 (average 1 week), 2 (average 2 weeks), 3 (average 3 weeks), 4 (average 4 weeks) and 5 (average 5 weeks)

  2. Change in Generalized Anxiety Disorder 7 score (Intermediate reports)

    Standard questionnaire for generalized anxiety symptoms. Total score is used; lower score indicates better outcome.

    Time frame: after modules 1 (average 1 week), 2 (average 2 weeks), 3 (average 3 weeks), 4 (average 4 weeks) and 5 (average 5 weeks)

  3. User experience survey

    Computerized survey to get user feedback on the features of the program

    Time frame: after module 3 (average 3 weeks) and module 6 (upto 90 days) of program

  4. Change in Patient Health Questionnaire-9 score (for clinician-referred participants)

    The subset of participants that are referred to the trial by a clinician can be analyzed separately to test the effectiveness of the program when used with a clinician's referral. Total score is used; lower score indicates better outcome.

    Time frame: baseline, post-completion or last usage (upto 90 days), 90 day follow-up after completion

  5. Change in Generalized Anxiety Disorder 7 score (for clinician-referred participants)

    The subset of participants that are referred to the trial by a clinician can be analyzed separately to test the effectiveness of the program when used with a clinician's referral. Total score is used; lower score indicates better outcome.

    Time frame: baseline, post-completion or last usage (upto 90 days), 90 day follow-up after completion

07

Study locations

1 site
  • Indian Institute of Technology Kanpur
    Kanpur, Uttar Pradesh 208016, India
08

References and documents

Publications

  • Gilbody S, Brabyn S, Lovell K, Kessler D, Devlin T, Smith L, Araya R, Barkham M, Bower P, Cooper C, Knowles S, Littlewood E, Richards DA, Tallon D, White D, Worthy G; REEACT collaborative. Telephone-supported computerised cognitive-behavioural therapy: REEACT-2 large-scale pragmatic randomised controlled trial. Br J Psychiatry. 2017 May;210(5):362-367. doi: 10.1192/bjp.bp.116.192435. Epub 2017 Mar 2. PubMed 28254959 ↗
  • Gilbody S, Littlewood E, Hewitt C, Brierley G, Tharmanathan P, Araya R, Barkham M, Bower P, Cooper C, Gask L, Kessler D, Lester H, Lovell K, Parry G, Richards DA, Andersen P, Brabyn S, Knowles S, Shepherd C, Tallon D, White D; REEACT Team. Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial. BMJ. 2015 Nov 11;351:h5627. doi: 10.1136/bmj.h5627. Erratum In: BMJ. 2016 Jan 12;352:i195. doi: 10.1136/bmj.i195. PubMed 26559241 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2018 to primary completion in Mar 2019, 12 months.

Of 3,471 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 12 months is below that.

Counting every sponsor, half of 3,569 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 14, 2018
First posted
Feb 26, 2018
StartActual
Feb 14, 2018
Primary completionActual
Mar 2, 2019
CompletionActual
May 31, 2019
Last update
Jul 2, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03445598
Lead sponsor
Indian Institute of Technology Kanpur
Responsible party
Nitin Gupta (Assistant Professor, Indian Institute of Technology Kanpur) — Principal investigator
First posted
Feb 26, 2018
Start date
Feb 14, 2018
Primary completion
Mar 2, 2019
Completion
May 31, 2019
Last update
Jul 2, 2019

Study contacts

Nitin Gupta, PhD
principal investigator · Indian Institute of Technology Kanpur

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion